CERO vs GILD: Which Stock is Better?
Side-by-side comparison of Cero Therapeutics Holdings Inc and Gilead Sciences Inc in 2026
CERO
Cero Therapeutics Holdings Inc
$0.04
GILD
Gilead Sciences Inc
$137.64
Key Metrics Comparison
| Metric | CERO | GILD | Winner |
|---|---|---|---|
| Market Cap | $0.84M | $170.84B | GILD |
| P/E Ratio | N/A | 20.27 | GILD |
| EPS (TTM) | $N/A | $6.79 | GILD |
| Revenue Growth | 0.0% | 0.0% | GILD |
| Gross Margin | 0.0% | 78.8% | GILD |
Analyze CERO
Full quant analysis
Analyze GILD
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is CERO or GILD a better investment?
Comparing CERO and GILD: Cero Therapeutics Holdings Inc has a market cap of $0.84M while Gilead Sciences Inc has $170.84B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between CERO and GILD?
CERO (Cero Therapeutics Holdings Inc) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: CERO or GILD?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: CERO or GILD?
GILD has higher revenue growth at 0.0% vs 0.0% for CERO.
Which company is more profitable: CERO or GILD?
Gilead Sciences Inc (GILD) has higher gross margins at 78.8% compared to 0.0% for CERO.
Which is the larger company: CERO or GILD?
Gilead Sciences Inc (GILD) is larger with a market cap of $170.84B compared to $0.84M for CERO.
Should I buy CERO or GILD in 2026?
Both CERO and GILD have investment merit. CERO trades at $0.04 while GILD trades at $137.64. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between CERO and GILD stock?
Key differences: Market Cap ($0.84M vs $170.84B), P/E Ratio (N/A vs 20.3x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 78.8%).